Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
1992 StandoutNature
Stromal fibroblasts in cancer initiation and progression
2004 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
New insights into nNOS regulation of vascular homeostasis
2005 StandoutNobel
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
2014 StandoutNature
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
1992 StandoutNature
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
Expression of Vascular Endothelial Growth Factor Receptor 1 in Bone Marrow-derived Mesenchymal Cells Is Dependent on Hypoxia-inducible Factor 1
2006 StandoutNobel
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
2005 StandoutNobel
Induction of angiogenesis during the transition from hyperplasia to neoplasia
1989 StandoutNature
Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth
1997 Standout
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
1990
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Angiogenesis in life, disease and medicine
2005 StandoutNature
The microenvironment of the tumour–host interface
2001 StandoutNature
Malignant Gliomas in Adults
2008 Standout
VEGF and the quest for tumour angiogenesis factors
2002
VEGF-A: a critical regulator of blood vessel growth
2009
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
1995 StandoutNature
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma
1994 Standout
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Oxygen Sensing, Homeostasis, and Disease
2011 StandoutNobel
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Angiogenesis as a therapeutic target
2005 StandoutNature
LRG1 promotes angiogenesis by modulating endothelial TGF-β signalling
2013 StandoutNature
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
1993 StandoutNature
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Vascular Permeability Factor, an Endothelial Cell Mitogen Related to PDGF
1989 StandoutScience
Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels.
1975
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
2011
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Anti-Angiogenesis
1972
The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
1992 StandoutScience
Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance
2001 StandoutNobel
Tumor Angiogenesis: Therapeutic Implications
1971 Standout
Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model
1998 StandoutScience
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
1989 StandoutScience
Angiogenic Factors
1987 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
1996 StandoutNobel
Requirement of Vascular Integrin α v β 3 for Angiogenesis
1994 StandoutScience
Genes Expressed in Human Tumor Endothelium
2000 StandoutScience
An Unusual Type of Cytokeratin Filament in Cells of a Human Cloacogenic Carcinoma Derived from the Anorectal Transition Zone
1982
Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1
1994 StandoutScience
Migration Inhibition of Endothelial Cells by Lymphokine-Containing Supernatants
1982 StandoutScienceNobel
Geometric Control of Cell Life and Death
1997 StandoutScience
The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells
1982 Standout
ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS
1971
Works of Mogens Knoth being referenced
The Anal Transitional Zone: A Scanning and Transmission Electron Microscopic Investigation of the Surface Epithelium
1981
Choriocarcinoma: Transfilter Stimulation of Vasoproliferation in the Hamster Cheek Pouch—Studied by Light and Electron Microscopy<xref ref-type="fn" rid="FN2">2</xref>
1968